Alereve

Ocular allergies affect approximately 60 million Americans in the US with approximately 50% having concomitant Dry Eye Syndrome (more than 30 million Americans having both conditions). Currently, the leading therapeutic option for patients with ocular allergies is topical antihistamines which will routinely improve their allergic component but unfortunately can worsen their Dry Eye Syndrome. Developed by leading Ophthalmologists specializing in allergies, Alereve is an all natural proprietary blend that is positioned to be the Therapy-of-Choice for patients with ocular allergies. Clinically proven to treat the patient’s underlying allergic condition without the unwanted side effects of dryness. Seeing this huge unmet need, Alereve was developed to better treat these patient’s ocular allergies without exacerbating their dry eye component. In fact, our initial study demonstrated that some patient’s Dry Eye Syndrome was significantly improved with Alereve treatment. Fortunately, you don’t need a prescription to benefit from Alereve and can get it directly from Eye Doctors.